Changes in Cardiovascular Health Status and Risk of Sudden Cardiac Death in Older Adults by 김태훈 et al.
298 www.eymj.org
INTRODUCTION
Sudden cardiac death (SCD) accounts for approximately 25% 
of the global mortality from cardiovascular disease (CVD).1,2 
Despite the importance and societal burden of SCD, current 
preventive strategies for SCD are limited. Several clinical risk 
factors, including hypertension, diabetes mellitus (DM), dys-
lipidemia, smoking, and physical inactivity are associated with 
SCD.3,4 Modification of these clinical factors might reduce the 
risk of SCD; hence, an effective risk stratification strategy is nec-
essary. The American Heart Association (AHA) committee 
has developed a new concept of cardiovascular health (CVH) 
status and proposed metrics thereof that need to be moni-
tored over time.5 The CVH metrics comprise seven modifiable 
behavioral and biologic metrics. Previous studies have re-
vealed a strong association between CVH status and various 
cardiovascular outcomes.6-9 In a recent study conducted in Fin-
land, a high CVH score at baseline substantially reduced the 
risk of SCD among middle-aged men.10 Although several stud-
ies have assessed the incidence of SCD,11 limited data are avail-
able regarding the predictors of SCD in older adults.12-14 The 
effects of changes in CVH status, in particular, over time on 
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SCD in older adults have not been widely studied. Therefore, 
we evaluated whether baseline CVH status and changes in 
CVH status over time are associated with a reduced risk of SCD 
in an older adult population. Further, we assessed whether in-
dividual CVH metrics are associated with a reduced risk of 
SCD. We also evaluated the risk of all-cause death with chang-
es in CVH status.
MATERIALS AND METHODS
Data were collected from the Korea National Health Insurance 
Service (NHIS)-Senior, which contains data on 558147 individ-
uals, accounting for approximately 10% of the entire older 
adult population aged ≥60 years in South Korea (about 5.1 mil-
lion) from 2002.15 The NHIS-Senior database includes the fol-
lowing: sociodemographic and socioeconomic information, 
insurance status, health checkup data, and records of patient 
medical and dental history. These parameters were stratified 
to cover 12 years (2002–2013) and anonymized to protect the 
privacy of individuals included in this cohort study. This study 
was approved by the Institutional Review Board of Yonsei Uni-
versity Health System (4-2020-0703). The need for informed 
consent was waived. The NHIS-Senior database used in this 
study (NHIS-2016-2-171) is maintained by NHIS. The authors 
declare no conflicts of interest with NHIS.
Study population
From the NHIS-Senior database, 312736 patients who under-
went health checkups between 2005 and 2012 and who had 
follow-up data until December 2013 were enrolled. Patients 
with a body mass index (BMI) <18.5 kg/m2 (n=15446), hyper-
trophic cardiomyopathy (n=686), a history of heart failure (n= 
25819), ischemic stroke or transient ischemic attack (n=29163), 
myocardial infarction (n=8874), hemorrhagic stroke (n=1075), 
venous thromboembolism (n=1430), malignancy (n=23432), 
and missing data on CVH metrics (n=5843) were excluded. 
The remaining 197241 participants were included for analysis 
(Fig. 1).
Covariates
Baseline comorbidities were identified from medical claims 
data and prescription medication information prior to the in-
dex date. To ensure diagnostic accuracy, the patients were con-
sidered to have comorbidities when the condition was men-
tioned as a diagnosis at discharge or had been confirmed at 
least twice in an outpatient setting. This was in line with previ-
ous studies using the NHIS database (Supplementary Table 1, 
only online).12,15-18 Economic status variables were catego-
rized into low, intermediate, and high status based on the total 
amount of national health insurance premiums paid by an in-
sured person in each year, which are proportional to the per-
son’s income.
CVH
The AHA criteria were used to calculate CVH scores from six 
metrics (smoking, physical activity, BMI, blood pressure, fast-
ing blood glucose concentrations, and blood total cholesterol) 
(Supplementary Table 2, only online). The scores for each met-
ric ranged from 0 to 2 (0, poor metrics; 1, intermediate metrics; 
and 2, points for ideal metrics). Thus, the sum of CVH scores 
in an individual ranged from 0 to 12. Change in CVH scores 
was calculated and examined for participants whose CVH 
scores for an initial and follow-up health checkup were avail-
able. Based on the mean value of 6, changes in CVH status were 
categorized as consistent high (≥7 to ≥7), high to low (≥7 to 
≤6), low to high (≤6 to ≥7), and consistent low (≤6 to ≤6). The 
median interval between the initial and follow-up health check-
ups was 2.0 years. 
Ascertainment of SCD
In the NHIS-Senior database, we identified patients with SCD 
using the International Classification of Diseases, 10th revi-
sion codes I46.x (cardiac arrest) and I49.0 (ventricular fibrilla-
tion). To avoid erroneous inclusion of patients with non-cardiac 
death, we excluded patients with sudden death accompanied 
by respiratory arrest (R09.0 and R09.2), gastrointestinal bleed-
ing (I85.0, K25.0, K25.4, K26.0, K26.4, K27.0, K27.4, and K92.0–
K92.2), brain hemorrhage (I60.x–I62.x and S06.4–S06.6), sep-
tic shock (A41.9 and R57.2), pregnancy and delivery (O00–
O99), diabetic ketoacidosis (E14.1), anaphylaxis (T78.2), and 
accidents including asphyxiation, drowning, poisoning, traffic 
accident, fall, and suicide (T71, T75.1, T36–T65, V01–V99, W00–
W99, X60–X84, respectively). The positive predictive value of 
558147 elderly population equal or older than 60 years 
in 2002 registered in NHIS-Senior cohort*
312736 who received national health check-ups 
between 2005–2012 were assessed for eligibility
197241 subjects with the 1st health check-up
105200 subjects with the 2nd health check-up




- BMI ≤18.5 (n=15446)
- HCMP (n=686)
- Previous MI (n=8874)
- Heart failure (n=25819)
- Ischemic stroke or TIA (n=29163)
- Hemorrhagic stroke (n=1075)
- Venous thromboembolism (n=1430)
- Malignancy (n=23432)
- Missing data (n=5843)
Fig. 1. Screening and study flowchart of the participants. *Korean Na-
tional Health Insurance Service (NHIS)-Senior cohort. BMI, body mass 
index; HCMP, hypertrophic cardiomyopathy; MI, myocardial infarction; 
TIA, transient ischemic attack; SCD, sudden cardiac death.
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our criteria of SCD was 80.2% (586 of 731), which suggests good 
diagnostic accuracy.12
Statistical analysis
Baseline characteristics of the participants were compared us-
ing descriptive statistics and are presented as median (inter-
quartile interval) values for continuous variables and number 
(percentage) for categorical variables. Changes in CVH status 
based on 12-point CVH scores and the number of ideal met-
rics (0–6) were used as time-varying variables in Cox propor-
tional hazards regression models. For each CVH metric, time-
varying Cox regression analysis was performed. The rates of 
events were calculated by dividing the number of events by 
1000 person-years at risk, with 95% confidence intervals (CIs) 
estimated using exact Poisson distributions. Competing risk 
analysis was performed using the Fine and Gray method,19 and 
sub-distribution hazard ratios (sHR) were estimated to deter-
mine the association of changes in CVH with SCD and all-
cause death. Time-varying variables for change in CVH status 
were used to estimate hazard ratios (HR) in subgroup analy-
sis. For each subgroup analysis for SCD and all-cause death, a 
p value for interaction was calculated, and a value of <0.05 de-
noted a statistically significant difference between the sub-
groups. The Kaplan-Meier method was used to compare the 
cumulative incidence difference (CID) from baseline to 72 
months among the four CVH groups, with adjustment for co-
variates. Two-sided p values of <0.05 were considered signifi-
cant. Statistical analyses were performed using SAS, version 9.4 
(SAS Institute, Cary, NC, USA) and R, version 4.0.0 (R Founda-
tion for Statistical Computing, Vienna, Austria).
RESULTS
The baseline characteristics and CVH statuses of the study par-
ticipants at the initial and follow-up health checkups are 
shown in Table 1. At baseline, the median patient age was 70 
years. Of the total participants, 43.4% were men and 50.9% had 
hypertension. The median CVH score was 8 points at the first 
and second health checkups. In 71.4% participants, the CVH 
score was high at baseline. There were no differences in the 
baseline characteristics and CVH statuses between first and 
second health checkups. 
Time-varying CVH status and risk of SCD and 
all-cause death
Over a median follow-up of 7.2 years after baseline, there were 
1674 SCDs and 20223 all-cause deaths. Compared to low CVH 
status, high CVH status was associated with a lower risk of SCD 
(HR, 0.70; 95% CI, 0.63–0.78) and all-cause death (HR, 0.80; 95% 
CI, 0.78–0.82) after adjusting for age, sex, economic status, pres-
ence of coronary heart disease (CHD), hypertension, DM, ane-
mia, and chronic obstructive pulmonary disease. For each ad-
ditional time-varying point in the 12-point CVH scores (HR, 
0.91; 95% CI, 0.88–0.93) and cardiovascular ideal metrics (HR, 
0.93; 95% CI, 0.89–0.97), the risk of SCD decreased continu-
ously. Similar results were seen for all-cause death (Table 2). 
Subgroup analysis showed that the risk of SCD reduced 
consistently with higher CVH status, regardless of age, sex, 
CHD, hypertension, DM, and anemia. In patients with chronic 
obstructive pulmonary disease (COPD), high CVH status did 
not reduce the risk of SCD, compared with those without COPD 
(Fig. 2). In patients with age <75 years, male sex, absence of 
hypertension or COPD, high CVH status was significantly re-
duced the risk of all-cause death compared with their counter-
parts (Fig. 3). 







Age (yr) 70 (66, 74) 70 (68, 72)
Men 85415 (43.3) 48416 (46.0)
Economic status
Low 74508 (37.8) 39692 (37.7)
Intermediate 88097 (44.7) 46821 (44.5)
High 34636 (17.5) 18687 (17.8)
Hypertension 100437 (50.9) 53471 (50.8)
Diabetes mellitus 26894 (13.6) 13783 (13.1)
Dyslipidemia 58807 (29.8) 31910 (30.3)
Coronary heart disease 1734 (0.9) 938 (0.9)
Chronic kidney disease 1837 (0.9) 928 (0.9)
Anemia 31357 (15.9) 15506 (14.8)
Hyperthyroidism 4353 (2.2) 2273 (2.2)
Hypothyroidism 4732 (2.4) 2520 (2.4)
Chronic obstructive pulmonary disease 11862 (6.0) 6149 (5.8)
Chronic liver disease 39252 (19.9) 21518 (20.5)
No. of ideal metrics* 3 (2, 4) 3 (2, 4)
No. of ideal CVH metrics*
Low, 0–1  25128 (12.7) 13172 (12.5)
Moderate, 2–3 120381 (61.0) 64042 (60.9)
High, 4–6 51732 (26.3) 27986 (26.6)
12–point CVH scores† 8 (6, 8) 8 (6, 9)
CVH status by 12–point CVH scores†
Low, 0–6 56327 (28.6) 29320 (27.8)
High, 7–12  140914 (71.4) 75880 (72.2)
CVH, cardiovascular health.
The data are presented as a number (%) and median (interquartile). Non-
parametric continuous variables that were evaluated using the Kolmogorov-
Smirnov method were analyzed using a Mann-Whitney U test.
*The CVH metrics included smoking, body mass index, physical activity, blood 
pressure, fasting plasma glucose, and plasma total cholesterol, †The continu-
ous 12-point CVH score (range, 1–12; higher score indicating higher CVH) was 
calculated by assigning 0 (poor), 1 (intermediate), and 2 (ideal) points to each 
of the 6 metrics (listed in footnote*) and summing them.
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Individual CVH metrics and the risk of SCD and 
all-cause death
Supplementary Table 3 (only online) shows time-varying haz-
ards of individual CVH metrics. An increase in scores toward 
the ideal CVH status afforded a significantly reduced risk of 
SCD. Compared with poor CVH scores, ideal CVH scores for 
smoking, physical activity, blood pressure, fasting glucose, and 
total cholesterol were significantly associated with 39%, 18%, 
20%, 34%, and 18% reductions in the risk of SCD, respectively. 
The associations remained significant for the risk of all-cause 
death. However, ideal BMI was not associated with a reduced 
risk of SCD or all-cause death. The findings of Cox proportion-
al regression analysis based on baseline CVH metrics were 
similar to those of the time-varying analysis. However, the ef-
fects were weaker on SCD, especially in smoking, blood pres-
sure, fasting glucose, and total cholesterol components (Sup-
plementary Table 4, only online).
Changes in CVH status, SCD, and all-cause death
During the median follow-up of 5.2 years after the second health 
checkup, there were 688 SCDs and 7741 all-cause deaths. Base-
line characteristics and CVH status of all patients with SCD 
and all-cause death are presented in Supplementary Table 5 
(only online). 
Table 3 shows the results of incidence rate ratio and com-
peting risk analysis in participants whose CVH scores for an 
initial and follow-up health checkup were available. Based on 
baseline CVH status, 27.9% and 72.1% participants were di-
vided into the low- and high-level groups, respectively. At 
baseline, compared to participants in the low group, those in 
the high group had a lower risk of SCD (adjusted sHR, 0.82; 95% 
CI, 0.70–0.97) and all-cause death (adjusted sHR, 0.82; 95% CI, 
0.70–0.97), respectively. The incidence rates also showed lower 
risks of SCD (adjusted HR, 0.81; 95% CI, 0.69–0.95) and all-
cause death (adjusted HR, 0.80; 95% CI, 0.78–0.85). To assess 
the association between change in CVH status and risk of SCD, 
Fig. 2. Subgroup analysis of SCD by time-varying Cox proportional model per 1-point increase in the 12-point CVH scores. SCD, sudden cardiac death; 
CAD, coronary artery disease; HTN, hypertension; DM, diabetes mellitus, COPD, chronic obstructive pulmonary disease; HR, hazard ratio; CI, confi-
dence interval, CVH, cardiovascular health.
Table 2. Time-Varying Cox Proportional Hazards Model for Incident SCD and All-Cause Death from the Initial Health Checkup (n=197241)
CVH status adjusted HR (95% CI)*
CVH status by 12-point CVH scores
Per 1-point increase in the 12-point CVH scores Per additional ideal metric
Low, ≤6 High, ≥7
SCD (n=1674) 1 [Reference] 0.70 (0.63–0.78) 0.91 (0.88–0.93) 0.93 (0.89–0.97)
All-cause death (n=20223) 1 [Reference] 0.80 (0.78–0.82) 0.93 (0.92–0.94) 0.97 (0.96–0.98)
CI, confidence interval; CVH, cardiovascular health; HR, hazard ratio; SCD, sudden cardiac death.
*HRs and 95% CIs were estimated using Cox proportional hazards models stratified by a 2-year interval between the first and second health checkups as a time-
varying variable, adjusted by age, sex, economic status, coronary heart disease, hypertension, diabetes mellitus, anemia, and chronic obstructive pulmonary dis-
ease over a median follow-up of 7.2 (interquartile range, 5.1–8.1) years starting from the first health checkup.
Age     0.474
   >75 511/33742 33231/33742 0.68 0.56–0.82 
   ≤75 1163/163499 162336/163499 0.71 0.62–0.80 
Sex     0.368
   Men 974/85415 84171/85415 0.67 0.59–0.77 
   Women 700/111826 111126/111826 0.75 0.63–0.88 
CAD     0.223
   No 1649/195507 193858/195507 0.70 0.63–0.78 
   Yes 25/1743 1709/1734 0.46 0.20–1.04 
HTN     0.540
   No 791/96804 96013/96804 0.69 0.59–0.80 
   Yes 883/100437 99554/100437 0.71 0.62–0.81 
DM     0.823
   No 1365/170347 168982/170347 0.70 0.63–0.79 
   Yes 309/26894 26585/26894 0.67 0.54–0.85 
Anemia     0.799
   No 1303/165687 164384/165687 0.68 0.61–0.76 
   Yes 368/31357 30989/31357 0.76 0.60–0.95 
COPD     0.018
   No 1519/185379 183860/185379 0.68 0.61–0.75 
   Yes 155/11862 1707/11862 0.97 0.68–1.39 
No./total No.
SCD (+)                      SCD (-)
HR          95% CI                 p for interaction
0.1                                             1                                              10
CVH status high better      CVH status low better
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we constructed four groups using a cutoff score of 6 points. The 
consistent low status group was used as the reference. While 
the CVH status of 15.9% participants improved from low to 
high, the CVH status of 9.5% participants deteriorated from 
high to low. Of the 74.6% participants with a stable CVH status, 
11.9% had a consistent low CVH status, and 62.7% had consis-
Age     0.046
   >75 7466/33742 26276/33742 0.84 0.79–0.88 
   ≤75 12757/163499 150742/163499 0.79 0.76–0.82 
Sex     <0.001
   Men 12152/85415 73236/85415 0.77 0.74–0.80 
   Women 8071/111826 103755/111826 0.88 0.84–0.92 
CAD     0.532
   No 20055/195507 175452/195507 0.80 0.78–0.83 
   Yes 168/1743 1566/1734 0.88 0.63–1.21 
HTN     0.007
   No 9428/96804 87376/96804 0.77 0.73–0.80 
   Yes 10795/100437 89642/100437 0.83 0.80–0.87 
DM     0.810
   No 16690/170347 153657/170347 0.80 0.78–0.83 
   Yes 3533/26894 23361/26894 0.80 0.75–0.86 
Anemia     0.471
   No 15665/165687 150022/165687 0.79 0.77–0.82 
   Yes 4515/31357 26842/31357 0.84 0.78–0.90 
COPD     0.002
   No 18370/185379 167009/185379 0.79 0.77–0.82 
   Yes 1853/11862 10009/11862 0.94 0.85–1.05 
                         No./total No.
All-cause death (+)         All-cause death (-) HR          95% CI             p for interaction
0.5                                           1                                             2
CVH status high better      CVH status low better
Fig. 3. Subgroup analysis of all-cause death by time-varying Cox proportional model per 1-point increase in the 12-point CVH scores. SCD, sudden 
cardiac death; CAD, coronary artery disease; HTN, hypertension; DM, diabetes mellitus, COPD, chronic obstructive pulmonary disease; HR, hazard ra-
tio; CI, confidence interval, CVH, cardiovascular health.
Table 3. Incident SCD, All-Cause Death, and Sub-Distribution Hazard Model for the Competing Risk of CVH Status Changes between Unitial and Follow-
Up Health Checkups (n=105200)
Incidence rate per 1000 
person-years (95% CI)






Low (n=29320) 0.12 (0.10–0.13) [Reference] [Reference]
High (n=75880) 0.09 (0.08–0.10) 0.81 (0.69–0.95)   0.012 0.82 (0.70–0.97)   0.019
CVH status change*
Low to low (n=12550) 0.13 (0.11–0.16) [Reference] [Reference]
Low to high (n=16770) 0.11 (0.09–0.13) 0.89 (0.69–1.14)   0.357 0.87 (0.67–1.12)   0.270
High to low (n=9983) 0.14 (0.12–0.17) 1.10 (0.84–1.44)   0.483 1.12 (0.86–1.46)   0.400
High to high (n=65897) 0.08 (0.07–0.09) 0.69 (0.56–0.86) <0.001 0.69 (0.55–0.85) <0.001
All-cause death (n=7741)
Baseline CVH status*
Low (n=29320) 1.34 (1.29–1.39) [Reference] [Reference]
High (n=75880) 1.00 (0.97–1.02) 0.80 (0.78–0.85) <0.001 0.81 (0.77–0.85) <0.001
CVH status change*
Low to low (n=12550) 1.46 (1.39–1.54) [Reference] [Reference]
Low to high (n=16770) 1.24 (1.18–1.31) 0.87 (0.82–0.94) <0.001 0.88 (0.82–0.95)   0.014
High to low (n=9983) 1.21 (1.13–1.29) 0.86 (0.79–0.93) <0.001 0.83 (0.77–0.91) <0.001
High to high (n=65897) 0.96 (0.93–0.99) 0.74 (0.69–0.78) <0.001 0.74 (0.70–0.79) <0.001
CI, confidence interval; CVH, cardiovascular health; HR, hazard ratio; sHR, sub-distribution hazard ratio; SCD, sudden cardiac death.
Change in CVH status was computed over a median time interval of 2.0 (interquartile range 1.7–2.3) years in participants who were free from SCD and all-cause 
death within this time interval.
*The two statuses were defined as CVH score low (those with 12-point CVH score ≤6 at baseline) and high (≥7 baseline) as used in the Framingham Offspring 
Study, †HRs and 95% CIs were estimated using Cox proportional hazards model with a median follow-up time of 5.2 (interquartile range 4.1–6.3) years from the 
second health checkup. HRs were adjusted for age, sex, economic status, coronary heart disease, hypertension, diabetes mellitus, anemia, and chronic obstruc-
tive pulmonary disease, ‡sHRs and 95% CIs were estimated using Cox proportional hazards model using the Fine and Gray method for competing risk. HRs were 
adjusted for age, sex, economic status, coronary heart disease, hypertension, diabetes mellitus, anemia, and chronic obstructive pulmonary disease.
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tent high CVH status over time. Participants who had high CVH 
status throughout the study period had a lower risk of SCD (ad-
justed sHR, 0.69; 95% CI, 0.55–0.85) and all-cause death (ad-
justed sHR, 0.74; 95% CI, 0.70–0.79). This group also had a 
lower risk of incident SCD (adjusted HR, 0.69; 95% CI, 0.56–
0.86) and all-cause death (adjusted HR, 0.74; 95% CI, 0.69–
0.78) than the consistent low CVH status group. 
Kaplan-Meier curves and cumulative incidence rates through-
out the study period are shown in Fig. 4. At 72 months, the cu-
mulative incidence of SCD was lower in the consistent high 
group than in the consistent low group (CIDs, -0.003%; 95% CI, 
-0.006–-0.001), high to low group (CIDs, -0.004%; 95% CI, 
-0.007–-0.001), and low to high group (CIDs, -0.001%; 95% CI, 
-0.006–0) (Fig. 4A). The cumulative incidence rate of all-cause 
death was lower in the consistent high group than in the con-
sistent low group (CIDs, -0.032%; 95% CI, -0.041–-0.023), high 
to low group (CIDs, -0.013%; 95% CI, -0.022–-0.004), and low to 
high group (CIDs, -0.013%; 95% CI, -0.022–-0.014). The high to 
low group had a lower cumulative incidence of all-cause death 
(CIDs, -0.019%; 95% CI, -0.032–-0.007) than the consistent low 
group, different from the pattern seen for SCD (Fig. 4B).
DISCUSSION
In this study, a consistently high CVH status was associated 
with a lower risk and incident rate ratio of SCD than a consis-
tently low CVH status. Similarly, in time-varying Cox regression 
analysis, a high CVH score was associated with a lower risk of 
SCD than a low CVH score. These results were consistent re-
gardless of age, sex, presence of CHD, hypertension, DM, and 
anemia. Furthermore, a consistently high CVH status was as-
sociated with a lower risk and incident rate ratio of all-cause 
death than a consistently low CVH status.
CVH and elderly population
Several reports have described the beneficial effects of an ideal 
CVH status on health-related outcomes in middle-age patients; 
however, there are limited data available for older adults.20-23 
According to the studies that are available, ideal CVH scores 
for older individuals is 2–3 times lower than that for younger 
individuals. Gaye, et al.8 analyzed the trend of ideal CVH sta-
tus among an older French population and showed that a high-
er CVH status was highly beneficial in lowering the risk of mor-
tality and vascular events. Mozaffarian, et al.24 reported that 
combined lifestyle factors, including physical activity, diet, 
smoking, alcohol consumption, BMI, and waist circumference, 
were associated with the incidence of new-onset DM. Both 
these studies had a 9- to10-year follow-up period and evaluat-
ed the longitudinal effect of CVH. Although only four risk fac-
tors were used, several studies in older adult populations have 
shown that the ideal CVH level can increase survival and also 
reduce the risk of death after CVD events.25,26 Our study shows 
consistent evidence regarding the association between base-
line CVH status and risk of SCD and all-cause death in older 
adults.
Changes in CVH status, SCD, and all-cause death
Multiple clinical risk factors have been found to be associated 
with SCD in previous studies.3,4,27 A recent study conducted in 
Finland reported that the risk of SCD is higher in physically in-
active patients with CHD.28 The risk of SCD was also increased 
in highly active patients, compared to that in active patients. 
Another recent study conducted in Finland showed that base-
Number at risk, n 
   (cumulative incidence, %)
     Consistent low 12550 11752 (0.002) 10130 (0.004) 4689 (0.007)
     Low to high 16770 15633 (0.003) 12255 (0.007) 4243 (0.011)
     Hihg to low 9983 9198 (0.002) 7931 (0.005) 3950 (0.010)
     Consistent high 65897 57236 (0.003) 43071 (0.007) 17139 (0.011)
Absolute difference in
  cumulative incidence (95% CI), %
     Consistent high vs. consistent low -0.001 (-0.002 to 0) -0.002 (-0.004 to 0) -0.003 (-0.006 to -0.001)
     Consistent high vs. high to low -0.001 (-0.003 to 0) -0.003 (-0.005 to -0.001) -0.004 (-0.007 to -0.001)
     Consistent high vs. low to high 0 (0 to 0.001) 0 (-0.002 to 0.001) -0.001 (-0.006 to 0)
     Low to high vs. consistent low -0.001 (-0.003 to 0) -0.002 (-0.004 to 0) -0.003 (-0.005 to 0.003)
     High to low vs. consistent low 0 (-0.002 to 0.002) 0.001 (-0.002 to 0.004) 0.001 (-0.004 to 0.005)
     High to low vs. low to high 0.001 (0 to 0.003) 0.002 (0 to 0.005) 0.001 (-0.003 to 0.005)
Number at risk, n 
   (cumulative incidence, %)
     Consistent low 12550 11756 (0.027) 10134 (0.067) 4689 (0.116)
     Low to high 16770 15635 (0.025) 12258 (0.062) 4248 (0.107)
     Hihg to low 9983 9201 (0.019) 7934 (0.054) 3952 (0.097)
     Consistent high 65897 57244 (0.020) 43081 (0.049) 17145 (0.084)
Absolute difference in
  cumulative incidence (95% CI), %
     Consistent high vs. consistent low -0.007 (-0.011 to -0.002) -0.018 (-0.024 to -0.011) -0.032 (-0.041 to -0.023)
     Consistent high vs. high to low 0.001 (-0.003 to 0.004) -0.005 (-0.012 to 0.001) -0.013 (-0.022 to -0.004)
     Consistent high vs. low to high -0.005 (-0.009 to -0.002) -0.013 (-0.019 to -0.008) -0.013 (-0.022 to -0.014)
     Low to high vs. consistent low -0.001 (-0.007 to -0.004) -0.005 (-0.013 to -0.003) -0.010 (-0.021 to 0.002)
     High to low vs. consistent low -0.007 (-0.013 to 0.002) -0.013 (-0.022 to -0.003) -0.019 (-0.032 to -0.007)
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Fig. 4. Kaplan-Meier curves and cumulative incidences of (A) sudden cardiac death (SCD) and (B) all-cause death according to change in cardiovascular 
health status between the first and second health checkups.
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line CVH status was strongly and linearly associated with the 
future risk of SCD and all-cause death.10 In that study, ideal 
physical activity did not show an independent association with 
the risk of SCD, compared to poor physical activity, because 
the study included participants with high physical activity, 
which itself might be a cause of sudden death.29 However, in 
our study, ideal physical activity, which included vigorous 
activity, was related to lower risks of both SCD and all-cause 
death. In addition, our study evaluated changes in CVH status 
more accurately and had a larger sample size (n=105200) than 
previous studies. The Framingham Offspring study evaluated 
the trends in CVH status over a 20-year period and assessed the 
association between change in CVH status with subclinical 
and clinical CVD.9 They observed a decrease in ideal CVH sta-
tus over 20 years, which increased the odds of subclinical dis-
ease and the risk of CVD and all-cause death. Otherwise, Sloten, 
et al.30 reported that there was an inconsistent linear relation-
ship between the direction of change in CVH status and the 
risk of CVD. Our results showed that CVH changes of low to 
high and high to low did not have reduced the risk of SCD, com-
pared to consistently low CVH. In regards to all-cause death, 
individuals with these change in CVH had a reduced risk. This 
emphasizes the importance of maintaining a healthy lifestyle 
to prevent SCD among older adults, compared to the all-cause 
death, relatively.9 This inconsistent linear relationship was ob-
served in our results for the risk of SCD, but not of all-cause 
death.
Our study included a large number of participants in a sam-
ple representative of the older Korean adult population. We 
explicitly accounted for the competing risk of all-cause death, 
thus identifying the utility of CVH change, which was en-
riched for SCD and all-cause death. We studied the CVD pop-
ulation with an intermediate risk for SCD, where clinically 
meaningful stratification of risk is more likely to be observed. 
Majority of SCDs occur in subjects without a known heart dis-
ease; thus, risk prediction might be helpful, although it is con-
sidered a greater challenge. The prediction of SCD is essential 
for the identification and prevention of patients at risk. Al-
though an ejection fraction <35% or 30% is commonly consid-
ered as a major risk factor, <10% patients with myocardial in-
farction develop an ejection fraction <35%31 and most SCDs 
occur in patients with an ejection fraction >35%.1 We excluded 
subjects who were diagnosed with heart failure at baseline, 
and this approach represents the larger population who re-
quire assessment for the prediction of SCD. 
Limitations
This study has several limitations. First, in studies using admin-
istrative databases, coding inaccuracies can lead to errors. We 
used a definition that has already been validated in previous 
studies to minimize this possibility. Second, since the study 
design was observational and health examination of the sub-
jects was conducted at different hospitals and clinics, the pos-
sibility of unmeasured confounders cannot be ruled out. Third, 
we used only six metrics of CVH and excluded the diet metrics. 
There are no data from nationally representative samples that 
allows for adequate quantification of caloric expenditure; hence, 
inclusion of diet metrics can increase the risk of bias. There-
fore, it would be interesting to investigate how accurately the 
diet component can be measured in this cohort. Fourth, par-
ticipants in our study who survived until at least 65 years of 
age could be healthier and have higher socioeconomic status, 
compared to their counterparts. Finally, all-cause death was 
not classified into further categories. We, therefore, might have 
overestimated the benefit of high CVH status over time in this 
study. 
In older adults, maintaining a high CVH status is significantly 
associated with a lower risk of SCD and all-cause death. These 
findings may help risk stratification for the prediction of SCD 
and all-cause death.
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